IT8220274A0 - Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica. - Google Patents

Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica.

Info

Publication number
IT8220274A0
IT8220274A0 IT8220274A IT2027482A IT8220274A0 IT 8220274 A0 IT8220274 A0 IT 8220274A0 IT 8220274 A IT8220274 A IT 8220274A IT 2027482 A IT2027482 A IT 2027482A IT 8220274 A0 IT8220274 A0 IT 8220274A0
Authority
IT
Italy
Prior art keywords
pharmaceutical formulations
topical administration
formulations containing
new pharmaceutical
containing coenzyme
Prior art date
Application number
IT8220274A
Other languages
English (en)
Other versions
IT1157269B (it
Inventor
Alberto Bertelli
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11165341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8220274(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Seuref Ag filed Critical Seuref Ag
Priority to IT20274/82A priority Critical patent/IT1157269B/it
Publication of IT8220274A0 publication Critical patent/IT8220274A0/it
Priority to BE0/210350A priority patent/BE896205A/fr
Priority to DE19833309850 priority patent/DE3309850A1/de
Priority to FR8304506A priority patent/FR2523443B1/fr
Priority to JP58046988A priority patent/JPS58222016A/ja
Priority to GB08307759A priority patent/GB2116426B/en
Priority to US06/711,034 priority patent/US4654373A/en
Application granted granted Critical
Publication of IT1157269B publication Critical patent/IT1157269B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT20274/82A 1982-03-19 1982-03-19 Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica IT1157269B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT20274/82A IT1157269B (it) 1982-03-19 1982-03-19 Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
BE0/210350A BE896205A (fr) 1982-03-19 1983-03-18 Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
DE19833309850 DE3309850A1 (de) 1982-03-19 1983-03-18 Neue pharmazeutische coenzym q(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)0(pfeil abwaerts) enthaltende zubereitungen
FR8304506A FR2523443B1 (fr) 1982-03-19 1983-03-18 Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
JP58046988A JPS58222016A (ja) 1982-03-19 1983-03-19 局所投与に適する補酵素ｑ↓１↓０を含有する医薬組成物とその製剤法
GB08307759A GB2116426B (en) 1982-03-19 1983-03-21 New pharmaceutical formulations containing coenzyme q10
US06/711,034 US4654373A (en) 1982-03-19 1985-03-12 Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20274/82A IT1157269B (it) 1982-03-19 1982-03-19 Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica

Publications (2)

Publication Number Publication Date
IT8220274A0 true IT8220274A0 (it) 1982-03-19
IT1157269B IT1157269B (it) 1987-02-11

Family

ID=11165341

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20274/82A IT1157269B (it) 1982-03-19 1982-03-19 Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica

Country Status (7)

Country Link
US (1) US4654373A (it)
JP (1) JPS58222016A (it)
BE (1) BE896205A (it)
DE (1) DE3309850A1 (it)
FR (1) FR2523443B1 (it)
GB (1) GB2116426B (it)
IT (1) IT1157269B (it)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
JPS60100517A (ja) * 1983-11-08 1985-06-04 Eisai Co Ltd 放射線潰瘍治療剤および方法
JPS61210028A (ja) * 1985-03-15 1986-09-18 Eisai Co Ltd 褥瘡治療剤
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
JPS61289029A (ja) * 1985-06-11 1986-12-19 Shiseido Co Ltd 抗色素沈着剤
JPS6339813A (ja) * 1986-08-05 1988-02-20 Eisai Co Ltd 創傷治療剤
US4929437A (en) * 1989-02-02 1990-05-29 Merck & Co., Inc. Coenzyme Q10 with HMG-CoA reductase inhibitors
US5378461A (en) * 1991-07-12 1995-01-03 Neigut; Stanley J. Composition for the topical treatment of skin damage
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
WO1998035658A2 (de) * 1997-02-12 1998-08-20 Mse Pharmazeutika Gmbh Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
US6255354B1 (en) * 1997-02-12 2001-07-03 Mse Pharmazeutika Gmbh Preparation of a pulmonary surfactant for instillation and oral application
US6503483B2 (en) * 1997-06-12 2003-01-07 C.S. Bioscience, Inc. Dental formulation
US6207137B1 (en) 1997-06-12 2001-03-27 C.S. Bioscience, Inc. Dental formulation
US5908613A (en) * 1997-09-08 1999-06-01 Bozzacco; Craig Composition for the treatment and prevention of periodontal disease
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US6048886A (en) * 1998-10-05 2000-04-11 Neigut; Stanley Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
US6200550B1 (en) 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
US6106286A (en) * 1999-01-22 2000-08-22 Gupta; Subhash Method and device for administering medicine to the periodontium
DE19944137A1 (de) * 1999-09-15 2001-03-22 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
TWI287995B (en) * 2000-05-09 2007-10-11 Kaneka Corp Dermatological composition containing co-enzyme Q as active ingredient
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
US6372198B1 (en) * 2000-09-14 2002-04-16 Joseph M. Abbate Dentifrice for the mineralization and remineralization of teeth
US20040097472A1 (en) * 2000-11-14 2004-05-20 West Simon Michael Complexes of phosphate derivatives
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US6806069B2 (en) * 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
DE10111053A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen
US20030031688A1 (en) * 2001-04-02 2003-02-13 Dipak Ghosh Cosmetic composition with improved skin moisturizing properties
JP4745608B2 (ja) 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
DE10139851A1 (de) * 2001-08-14 2003-03-13 Beiersdorf Ag Hautpflegeprodukte mit einer Kombination aus Biotin, Ubichinonen und Cyclodextrinen
DE10146802A1 (de) * 2001-09-22 2003-04-24 Beiersdorf Ag Vitaminhaltige Hautpflegeprodukte
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
WO2003049774A1 (en) * 2001-12-13 2003-06-19 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7544674B2 (en) * 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
JP4690305B2 (ja) * 2003-01-17 2011-06-01 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗増殖性質を有する化合物
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
EP1696868A1 (en) * 2003-07-18 2006-09-06 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
EP2371363B1 (en) * 2004-01-22 2020-04-08 University of Miami Coenzyme Q10 formulations for use in the treatment of solid tumours
NZ549567A (en) 2004-03-03 2009-10-30 Vital Health Sciences Pty Ltd Formulations comprising a tocopheryl phosphate tertiary amine alkaloid complex
DE102004032837A1 (de) 2004-07-02 2006-02-09 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
US20090233881A1 (en) * 2005-03-03 2009-09-17 Vital Health Sciences Pty. Ltd Compounds having anti-cancer properties
JP2006248940A (ja) * 2005-03-09 2006-09-21 Eikodo Honten:Kk 皮膚若しくは毛髪用化粧料
ES2557475T3 (es) * 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
EP3607937A1 (en) 2007-03-22 2020-02-12 Berg LLC Topical formulations having enhanced bioavailability
KR20100136997A (ko) 2008-04-11 2010-12-29 싸이토테크 랩스, 엘엘씨 암세포에서 아폽토시스를 유도하는 방법 및 용도
SG10201402287TA (en) 2009-05-11 2014-07-30 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
DE102009027024A1 (de) 2009-06-18 2010-12-23 Henkel Ag & Co. Kgaa Antifalten-Kosmetikum mit Antioxidantien
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
EA032941B1 (ru) * 2010-03-12 2019-08-30 БЕРГ ЭлЭлСи ЛЕКАРСТВЕННЫЕ ФОРМЫ КОЭНЗИМА Q10 (CoQ10) ДЛЯ ВНУТРИВЕННОГО ВВЕДЕНИЯ И ИХ ПРИМЕНЕНИЕ
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
DE102010050570A1 (de) * 2010-11-05 2012-05-10 F. Holzer Gmbh Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINOCHINOLINE AS A KINASEHEMMER
WO2012138765A1 (en) 2011-04-04 2012-10-11 Berg Pharma Llc Methods of treating central nervous system tumors
CA2839270C (en) 2011-06-17 2018-09-18 Berg Llc Inhalable liposomal pharmaceutical compositions
MX380565B (es) 2013-04-08 2025-03-12 Berg Llc Terapias combinadas de coenzima q10 para el tratamiento de cáncer.
AU2014315186B2 (en) 2013-09-04 2020-02-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme Q10
DE102014208441A1 (de) 2014-05-06 2015-11-12 Beiersdorf Ag Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations- und/oder UV-empfindliche Wirkstoffe enthält
DE202014003722U1 (de) 2014-05-06 2014-06-05 Beiersdorf Ag Perlenförmige kosmetische Darreichungsformen
DE102014208450B4 (de) 2014-05-06 2017-04-06 Beiersdorf Ag Kosmetisches Produkt
DE102014208440B4 (de) 2014-05-06 2018-09-27 Beiersdorf Ag Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations- und/oder UV-empfindliche Wirkstoffe enthält
DE202014003724U1 (de) 2014-05-06 2014-05-14 Beiersdorf Ag Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations-und/oder UV-empfindliche Wirkstoffe enthält
PL2942045T3 (pl) 2014-05-06 2019-02-28 Beiersdorf Ag Kosmetyczne perłowe postaci preparatu
EP2942046B1 (de) 2014-05-06 2018-07-11 Beiersdorf AG Zubereitungen mit einer äußeren Gelphase und einer inneren partikulären Phase, die stabilisierte oxidations- und/oder UV-empfindliche Wirkstoffe enthält
DE102014208436B4 (de) 2014-05-06 2016-02-25 Beiersdorf Ag Perlenförmige kosmetische Darreichungsformen
DE102014208438A1 (de) 2014-05-06 2015-11-12 Beiersdorf Ag Perlenförmige kosmetische Darreichungsformen
DE102014208451A1 (de) 2014-05-06 2015-11-12 Beiersdorf Ag Kosmetisches Produkt
DE202014003725U1 (de) 2014-05-06 2014-05-14 Beiersdorf Ag Kosmetisches Produkt
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
ES2981002T3 (es) 2015-12-09 2024-10-04 Avecho Biotechnology Ltd Formulación farmacéutica
DE102016225095B4 (de) 2016-12-15 2024-08-29 Henkel Ag & Co. Kgaa "Kosmetische Gesichtspflegeformulierungen zur Stimulierung der körpereigenen Abwehr gegen freie Radikale"
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
DE102018210184A1 (de) 2018-06-22 2019-12-24 Beiersdorf Ag Kosmetisches Produkt, umfassend kosmetisches oder dermatologisches Produkt, enthaltend sichtbare, in einem transparenten, flüssigen oder gelförmigen Träger suspendierte Perlen, wobei die Perlen einen unangenehmen Eigengeruch entwickelnden kosmetischen oder dermatologischen Wirkstoff verkapseln

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317865A (en) * 1971-11-15 1973-05-23 Jujo Paper Co Ltd Biologically active composition
JPS5299223A (en) * 1976-02-14 1977-08-19 Eisai Co Ltd Medicines for alopecia areata
JPS5938202B2 (ja) * 1976-03-05 1984-09-14 エーザイ株式会社 難聴治療剤
JPS5489036A (en) * 1977-12-27 1979-07-14 Eisai Co Ltd Remedy and preventive for hypersensitivity to light
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
FR2472384A1 (fr) * 1979-12-27 1981-07-03 Sederma Sa Utilisation en cosmetologie de complexes naturels constitues d'ubiquinones et de phospholipides
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica

Also Published As

Publication number Publication date
GB2116426B (en) 1985-09-25
US4654373A (en) 1987-03-31
IT1157269B (it) 1987-02-11
GB8307759D0 (en) 1983-04-27
FR2523443B1 (fr) 1986-10-03
DE3309850A1 (de) 1983-09-29
GB2116426A (en) 1983-09-28
FR2523443A1 (fr) 1983-09-23
BE896205A (fr) 1983-07-18
JPS58222016A (ja) 1983-12-23

Similar Documents

Publication Publication Date Title
IT8220274A0 (it) Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica.
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
DE3169761D1 (en) Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them
DE2965284D1 (en) Pharmaceutical compositions for topical administration containing prostaglandins
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
IL63036A (en) Dosage units for oral administration
AU4796885A (en) Osmotic system for delivering drug to colon
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
AU587997B2 (en) Osmotic system for delivering drug to the colon
FI830678L (fi) Bio-laempliga jaernderivat, som inte foerorsakar magsaor, framstaellningsfoerfarande och till sakenhoerande farmaceutiska foereningar
FI822670A0 (fi) Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling
IL68456A (en) Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles
NZ196288A (en) Pharmaceutical active substance administration
FI831926A7 (fi) (+)-syanidan-3-olijohdannaisia sisältävät farmaseuttiset valmisteet ja niiden käyttö, uudet substituosubstituoidut (+)-syanidan-3-oli- johdannaiset ja menetelmät niiden vavalmistamiseksi.
IT8521945A0 (it) 2-piridilcarbossammide particolarmente per uso farmaceutico.
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
IT8119824A0 (it) Prodotto medicinale per uso topico contenente indometacina.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8349055A0 (it) B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
IT8521214A0 (it) Composizione farmaceutica solida per uso orale.
NL194231B (nl) Preparaat met geregelde afgifte voor orale toediening dat broomcriptine bevat.
FI831927A7 (fi) (+)-syanidan-3-oli- johdannaiset, menetelmät niiden valmistamiseksi, näitä yhdisteitä sisältävät farmasefarmaseuttiset valmisteet ja niiden käyttö.
KR870700363A (ko) 비타민 b12를 함유하는 비내 투여용 조성물

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970326